IOVA logo

Iovance Biotherapeutics (IOVA) Depreciation And Amortization

Annual D&A

$33.13 M
+$11.99 M+56.74%

December 31, 2023

Summary

Performance

1-Year Change

+56.74%

3-Year Change

+280.25%

5-Year Change

+3365.17%

15-Year Change

+3379.73%

IOVA Depreciation And Amortization Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

84.02%
IOVA annual depreciation & amortization is higher than 84.02% of companies in Healthcare sector

High & Low

All-time High

$33.13 M
IOVA annual depreciation & amortization is currently at an all-time high

3-Year Low

$13.98 M
IOVA annual depreciation & amortization is currently +136.96% above its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
IOVA previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

Feb 28, 2025
IOVA next annual earnings announcement is scheduled for Feb 28, 2025

Related metrics

Annual Total Expenses

$461.75 M
IOVA annual total expenses is $461.75 million

Annual Operating Expenses

$450.99 M
IOVA annual total operating expenses is $450.99 million

Annual Cost Of Goods Sold

$10.76 M
IOVA annual cost of goods sold is $10.76 million

Annual Interest Expense

-
IOVA annual interest expense value is unknown

Quarterly D&A

$11.15 M
+$284.00 K+2.61%

September 30, 2024

Summary

Performance

3-Month Change

+2.61%

1-Year Change

+12.53%

3-Year Change

+112.42%

5-Year Change

+112.42%

IOVA Quarterly D&A Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

85.07%
IOVA quarterly depreciation & amortization is higher than 85.07% of companies in Healthcare sector

High & Low

All-time High

$11.15 M
IOVA quarterly depreciation & amortization is currently at an all-time high

3-Year Low

$4.46 M
IOVA quarterly depreciation & amortization is currently +149.73% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
IOVA previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Feb 28, 2025
IOVA next earnings announcement is scheduled for Feb 28, 2025

Related metrics

Quarterly Total Expenses

$147.62 M
IOVA quarterly total expenses is $147.62 million

Quarterly Operating Expenses

$107.80 M
IOVA quarterly total operating expenses is $107.80 million

Quarterly Cost Of Goods Sold

$39.82 M
IOVA quarterly cost of goods sold is $39.82 million

Quarterly Interest Expense

-
IOVA quarterly interest expense value is unknown

TTM D&A

$41.63 M
+$1.27 M+3.15%

September 30, 2024

Summary

Performance

3-Month Change

+3.15%

1-Year Change

+11.51%

3-Year Change

+123.17%

5-Year Change

+123.17%

IOVA TTM D&A Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

85.07%
IOVA TTM depreciation & amortization is higher than 85.07% of companies in Healthcare sector

High & Low

All-time High

$41.63 M
IOVA TTM depreciation & amortization is currently at an all-time high

3-Year Low

$13.98 M
IOVA TTM depreciation & amortization is currently +197.80% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
IOVA previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Feb 28, 2025
IOVA next earnings announcement is scheduled for Feb 28, 2025

Related metrics

Annual Total Expenses

$461.75 M
IOVA annual total expenses is $461.75 million

Annual Operating Expenses

$450.99 M
IOVA annual total operating expenses is $450.99 million

TTM Cost Of Goods Sold

$82.82 M
IOVA TTM cost of goods sold is $82.82 million

TTM Interest Expense

-
IOVA TTM interest expense value is unknown

IOVA Depreciation And Amortization Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+56.7%+12.5%+11.5%
3 y3 years+280.3%+112.4%+123.2%
5 y5 years+3365.2%+112.4%+123.2%

IOVA Depreciation And Amortization Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+137.0%at high+149.7%at high+197.8%
5 y5-yearat high+307.8%at high+4323.8%at high+416.1%
alltimeall timeat high>+9999.0%at high>+9999.0%at high>+9999.0%

Iovance Biotherapeutics Depreciation And Amortization History

DateAnnualQuarterlyTTM
Sep 2024
-
$11.15 M(+2.6%)
$41.63 M(+3.2%)
Jun 2024
-
$10.86 M(+9.7%)
$40.36 M(+8.1%)
Mar 2024
-
$9.91 M(+2.0%)
$37.34 M(+12.7%)
Dec 2023
$33.13 M(+56.7%)
$9.71 M(-1.6%)
$33.13 M(+13.8%)
Sep 2023
-
$9.88 M(+25.9%)
$29.12 M(+19.1%)
Jun 2023
-
$7.84 M(+37.6%)
$24.45 M(+11.9%)
Mar 2023
-
$5.70 M(-0.2%)
$21.85 M(+3.4%)
Dec 2022
$21.14 M(+51.2%)
$5.71 M(+9.7%)
$21.14 M(+6.2%)
Sep 2022
-
$5.20 M(-0.9%)
$19.89 M(+6.6%)
Jun 2022
-
$5.25 M(+5.4%)
$18.66 M(+15.3%)
Mar 2022
-
$4.98 M(+11.5%)
$16.18 M(+15.8%)
Dec 2021
$13.98 M(+60.5%)
$4.46 M(+12.6%)
$13.98 M(-19.7%)
Sep 2021
-
$3.96 M(+42.8%)
$17.41 M(+26.6%)
Jun 2021
-
$2.78 M(+0.1%)
$13.75 M(+22.4%)
Mar 2021
-
$2.77 M(-64.9%)
$11.23 M(+28.9%)
Dec 2020
$8.71 M(+7.3%)
$7.89 M(+2471.0%)
$8.71 M(+8.0%)
Sep 2020
-
$307.00 K(+18.1%)
$8.07 M(-0.1%)
Jun 2020
-
$260.00 K(+3.2%)
$8.07 M(-0.4%)
Mar 2020
-
$252.00 K(-96.5%)
$8.10 M(-0.2%)
Dec 2019
$8.12 M(+749.7%)
$7.25 M(+2201.0%)
$8.12 M(+620.8%)
Sep 2019
-
$315.00 K(+9.0%)
$1.13 M(+6.0%)
Jun 2019
-
$289.00 K(+6.6%)
$1.06 M(+6.4%)
Mar 2019
-
$271.00 K(+7.5%)
$999.00 K(+4.5%)
Dec 2018
$956.00 K(+0.4%)
$252.00 K(+0.4%)
$956.00 K(+1.1%)
Sep 2018
-
$251.00 K(+11.6%)
$946.00 K(+0.5%)
Jun 2018
-
$225.00 K(-1.3%)
$941.00 K(-1.9%)
Mar 2018
-
$228.00 K(-5.8%)
$959.00 K(+0.7%)
Dec 2017
$952.00 K(-2.7%)
$242.00 K(-1.6%)
$952.00 K(-4.8%)
Sep 2017
-
$246.00 K(+1.2%)
$1.00 M(+10.9%)
Jun 2017
-
$243.00 K(+10.0%)
$902.00 K(-3.0%)
Mar 2017
-
$221.00 K(-23.8%)
$930.00 K(-4.9%)
Dec 2016
$978.00 K
$290.00 K(+95.9%)
$978.00 K(-1.8%)
Sep 2016
-
$148.00 K(-45.4%)
$996.00 K(-10.6%)
DateAnnualQuarterlyTTM
Jun 2016
-
$271.00 K(+0.7%)
$1.11 M(+2.9%)
Mar 2016
-
$269.00 K(-12.7%)
$1.08 M(+8.4%)
Dec 2015
$999.00 K(+1035.2%)
$308.00 K(+15.8%)
$999.00 K(+32.1%)
Sep 2015
-
$266.00 K(+10.8%)
$756.00 K(+52.6%)
Jun 2015
-
$240.00 K(+29.7%)
$495.30 K(+93.1%)
Mar 2015
-
$185.00 K(+184.6%)
$256.50 K(+191.1%)
Dec 2014
$88.00 K(+1157.1%)
$65.00 K(+1126.4%)
$88.10 K(+249.6%)
Sep 2014
-
$5300.00(+341.7%)
$25.20 K(+16.1%)
Jun 2014
-
$1200.00(-92.8%)
$21.70 K(+0.5%)
Mar 2014
-
$16.60 K(+690.5%)
$21.60 K(+208.6%)
Dec 2013
$7000.00(+12.9%)
$2100.00(+16.7%)
$7000.00(+7.7%)
Sep 2013
-
$1800.00(+63.6%)
$6500.00(+3.2%)
Jun 2013
-
$1100.00(-45.0%)
$6300.00(-7.4%)
Mar 2013
-
$2000.00(+25.0%)
$6800.00(+6.3%)
Dec 2012
$6200.00(+129.6%)
$1600.00(0.0%)
$6400.00(-113.2%)
Sep 2012
-
$1600.00(0.0%)
-$48.40 K(+56.6%)
Jun 2012
-
$1600.00(0.0%)
-$30.90 K(+123.9%)
Mar 2012
-
$1600.00(-103.0%)
-$13.80 K(-611.1%)
Dec 2011
$2700.00(-95.4%)
-$53.20 K(-378.5%)
$2700.00(-97.6%)
Sep 2011
-
$19.10 K(+2.1%)
$112.00 K(+17.6%)
Jun 2011
-
$18.70 K(+3.3%)
$95.20 K(+24.1%)
Mar 2011
-
$18.10 K(-67.7%)
$76.70 K(+30.9%)
Dec 2010
$58.60 K(+4407.7%)
$56.10 K(+2339.1%)
$58.60 K(+1992.9%)
Sep 2010
-
$2300.00(+1050.0%)
$2800.00(+250.0%)
Jun 2010
-
$200.00(>+9900.0%)
$800.00(-11.1%)
Mar 2010
-
$0.00(-100.0%)
$900.00(-25.0%)
Dec 2009
$1300.00(0.0%)
$300.00(0.0%)
$1200.00(0.0%)
Sep 2009
-
$300.00(0.0%)
$1200.00(0.0%)
Jun 2009
-
$300.00(0.0%)
$1200.00(0.0%)
Mar 2009
-
$300.00(0.0%)
$1200.00(0.0%)
Dec 2008
$1300.00
$300.00(0.0%)
$1200.00(+33.3%)
Sep 2008
-
$300.00(0.0%)
$900.00(+50.0%)
Jun 2008
-
$300.00(0.0%)
$600.00(+100.0%)
Mar 2008
-
$300.00
$300.00

FAQ

  • What is Iovance Biotherapeutics annual depreciation & amortization?
  • What is the all time high annual D&A for Iovance Biotherapeutics?
  • What is Iovance Biotherapeutics annual D&A year-on-year change?
  • What is Iovance Biotherapeutics quarterly depreciation & amortization?
  • What is the all time high quarterly D&A for Iovance Biotherapeutics?
  • What is Iovance Biotherapeutics quarterly D&A year-on-year change?
  • What is Iovance Biotherapeutics TTM depreciation & amortization?
  • What is the all time high TTM D&A for Iovance Biotherapeutics?
  • What is Iovance Biotherapeutics TTM D&A year-on-year change?

What is Iovance Biotherapeutics annual depreciation & amortization?

The current annual D&A of IOVA is $33.13 M

What is the all time high annual D&A for Iovance Biotherapeutics?

Iovance Biotherapeutics all-time high annual depreciation & amortization is $33.13 M

What is Iovance Biotherapeutics annual D&A year-on-year change?

Over the past year, IOVA annual depreciation & amortization has changed by +$11.99 M (+56.74%)

What is Iovance Biotherapeutics quarterly depreciation & amortization?

The current quarterly D&A of IOVA is $11.15 M

What is the all time high quarterly D&A for Iovance Biotherapeutics?

Iovance Biotherapeutics all-time high quarterly depreciation & amortization is $11.15 M

What is Iovance Biotherapeutics quarterly D&A year-on-year change?

Over the past year, IOVA quarterly depreciation & amortization has changed by +$1.24 M (+12.53%)

What is Iovance Biotherapeutics TTM depreciation & amortization?

The current TTM D&A of IOVA is $41.63 M

What is the all time high TTM D&A for Iovance Biotherapeutics?

Iovance Biotherapeutics all-time high TTM depreciation & amortization is $41.63 M

What is Iovance Biotherapeutics TTM D&A year-on-year change?

Over the past year, IOVA TTM depreciation & amortization has changed by +$4.30 M (+11.51%)